DE69224069T2 - Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält - Google Patents
Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthältInfo
- Publication number
- DE69224069T2 DE69224069T2 DE69224069T DE69224069T DE69224069T2 DE 69224069 T2 DE69224069 T2 DE 69224069T2 DE 69224069 T DE69224069 T DE 69224069T DE 69224069 T DE69224069 T DE 69224069T DE 69224069 T2 DE69224069 T2 DE 69224069T2
- Authority
- DE
- Germany
- Prior art keywords
- amino acid
- acid antagonist
- excitatoric
- product containing
- pharmaceutical combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75640191A | 1991-09-09 | 1991-09-09 | |
PCT/US1992/007540 WO1993004688A1 (en) | 1991-09-09 | 1992-09-02 | Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69224069D1 DE69224069D1 (de) | 1998-02-19 |
DE69224069T2 true DE69224069T2 (de) | 1998-07-02 |
Family
ID=25043303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69224069T Expired - Fee Related DE69224069T2 (de) | 1991-09-09 | 1992-09-02 | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält |
Country Status (16)
Country | Link |
---|---|
US (4) | US5407935A (de) |
EP (1) | EP0603301B1 (de) |
JP (1) | JP3218038B2 (de) |
AT (1) | ATE162075T1 (de) |
AU (1) | AU660717B2 (de) |
CA (1) | CA2115442C (de) |
DE (1) | DE69224069T2 (de) |
DK (1) | DK0603301T3 (de) |
ES (1) | ES2113957T3 (de) |
GR (1) | GR3026369T3 (de) |
MX (1) | MX9205127A (de) |
NO (1) | NO307645B1 (de) |
NZ (1) | NZ244243A (de) |
PT (1) | PT100850B (de) |
WO (1) | WO1993004688A1 (de) |
ZA (1) | ZA926837B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2115442C (en) * | 1991-09-09 | 2003-09-23 | Christopher Franklin Bigge | Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist |
US5318985A (en) * | 1991-12-20 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Potentiation of NMDA antagonists |
JPH07505908A (ja) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Nmda受容体のアロステリックモジュレーター |
US5854217A (en) | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
US6277825B1 (en) | 1996-07-22 | 2001-08-21 | University Of Utah Research Foundation | Use of conantokins for treating pain |
JP2001507924A (ja) | 1996-07-22 | 2001-06-19 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション | コナントキン類 |
US6172041B1 (en) | 1996-07-22 | 2001-01-09 | University Of Utah Research Foundation | Use of conantokins |
IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
IL139912A0 (en) * | 1998-05-26 | 2002-02-10 | Carlen Peter Louis | Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
US6399574B1 (en) | 2000-03-22 | 2002-06-04 | University Of Utah Research Foundation | Use of conantokins |
DE60137635D1 (de) * | 2000-06-28 | 2009-03-26 | Merck & Co Inc | Verwendung von allopurinol zur behandlung von bluthochdruck |
US20080051428A1 (en) * | 2002-05-15 | 2008-02-28 | Davis Paul J | Pyrroloquinoline quinone drugs and methods of use thereof |
US7276514B2 (en) * | 2002-05-15 | 2007-10-02 | Charitable Leadership Foundation - Medical Technology Acceleration Program | Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
US20050209317A1 (en) * | 2004-03-22 | 2005-09-22 | Apkarian A V | Method and compositions for treatment of chronic neuropathic pain |
US8461223B2 (en) | 2005-04-07 | 2013-06-11 | Aspen Aerogels, Inc. | Microporous polycyclopentadiene-based aerogels |
ITFI20050083A1 (it) * | 2005-04-29 | 2006-10-30 | Univ Firenze | Uso dell'acido chinurenico per la prevenzione e il trattamento dello shock |
JP2008545627A (ja) | 2005-05-09 | 2008-12-18 | タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド | 腎結石症を治療する方法 |
US9181486B2 (en) | 2006-05-25 | 2015-11-10 | Aspen Aerogels, Inc. | Aerogel compositions with enhanced performance |
EP2338492A1 (de) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Verfahren und Zusammensetzung zur Behandlung von Alzheimer |
WO2012033941A1 (en) | 2010-09-10 | 2012-03-15 | Takeda Pharmaceuticals North America, Inc. | Methods for concomitant treatment of theophylline and febuxostat |
US10806711B2 (en) | 2011-08-12 | 2020-10-20 | University Of Cincinnati | Method of treating acute decompensated heart failure with probenecid |
MX2015012547A (es) | 2013-03-13 | 2016-02-10 | Univ Cincinnati | Tratamiento de una disfuncion cardiaca diastolica con un agonista del receptor trpv2. |
US20170143681A1 (en) | 2015-11-02 | 2017-05-25 | Apkarian Technologies Llc | Methods and compositions for treating pain |
EP3427729A1 (de) * | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid zur behandlung von epileptischen erkrankungen, störungen oder zuständen |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4812458A (en) * | 1986-09-16 | 1989-03-14 | A/S Ferrosan | 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics |
DK146787A (da) * | 1987-03-23 | 1988-09-24 | Ferrosan | Heterocykliske forbindelser, deres fremstilling og anvendelse |
DK0624569T3 (da) * | 1991-02-28 | 1998-10-26 | Merrell Pharma Inc | MMDA-antagonister |
CA2115442C (en) * | 1991-09-09 | 2003-09-23 | Christopher Franklin Bigge | Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist |
-
1992
- 1992-09-02 CA CA002115442A patent/CA2115442C/en not_active Expired - Fee Related
- 1992-09-02 DE DE69224069T patent/DE69224069T2/de not_active Expired - Fee Related
- 1992-09-02 EP EP92919882A patent/EP0603301B1/de not_active Expired - Lifetime
- 1992-09-02 DK DK92919882T patent/DK0603301T3/da active
- 1992-09-02 JP JP50544593A patent/JP3218038B2/ja not_active Expired - Fee Related
- 1992-09-02 AU AU25943/92A patent/AU660717B2/en not_active Ceased
- 1992-09-02 ES ES92919882T patent/ES2113957T3/es not_active Expired - Lifetime
- 1992-09-02 AT AT92919882T patent/ATE162075T1/de not_active IP Right Cessation
- 1992-09-02 WO PCT/US1992/007540 patent/WO1993004688A1/en active IP Right Grant
- 1992-09-07 NZ NZ244243A patent/NZ244243A/en unknown
- 1992-09-08 PT PT100850A patent/PT100850B/pt not_active IP Right Cessation
- 1992-09-08 ZA ZA926837A patent/ZA926837B/xx unknown
- 1992-09-08 MX MX9205127A patent/MX9205127A/es not_active IP Right Cessation
-
1993
- 1993-04-19 US US08/049,228 patent/US5407935A/en not_active Expired - Fee Related
-
1994
- 1994-03-08 NO NO940809A patent/NO307645B1/no not_active IP Right Cessation
-
1995
- 1995-10-05 US US08/539,398 patent/US5627168A/en not_active Expired - Fee Related
-
1996
- 1996-12-31 US US08/775,637 patent/US5767119A/en not_active Expired - Fee Related
-
1998
- 1998-03-13 GR GR980400554T patent/GR3026369T3/el unknown
- 1998-03-27 US US09/049,495 patent/US5942513A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO307645B1 (no) | 2000-05-08 |
AU2594392A (en) | 1993-04-05 |
CA2115442C (en) | 2003-09-23 |
US5767119A (en) | 1998-06-16 |
US5407935A (en) | 1995-04-18 |
ZA926837B (en) | 1994-03-08 |
EP0603301B1 (de) | 1998-01-14 |
AU660717B2 (en) | 1995-07-06 |
PT100850B (pt) | 1999-07-30 |
NO940809D0 (no) | 1994-03-08 |
EP0603301A1 (de) | 1994-06-29 |
PT100850A (pt) | 1993-10-29 |
NO940809L (no) | 1994-03-08 |
ES2113957T3 (es) | 1998-05-16 |
WO1993004688A1 (en) | 1993-03-18 |
US5627168A (en) | 1997-05-06 |
GR3026369T3 (en) | 1998-06-30 |
CA2115442A1 (en) | 1993-03-18 |
JPH06510544A (ja) | 1994-11-24 |
JP3218038B2 (ja) | 2001-10-15 |
DE69224069D1 (de) | 1998-02-19 |
ATE162075T1 (de) | 1998-01-15 |
MX9205127A (es) | 1993-07-01 |
US5942513A (en) | 1999-08-24 |
NZ244243A (en) | 1995-07-26 |
DK0603301T3 (da) | 1998-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69224069D1 (de) | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält | |
IS4073A (is) | Nýtt fjölvirknislyf gegn aukningu mótstöðu | |
ATE235906T1 (de) | Substituierte phenylpyrimidine derivate, für die behandlung oder prevention von zns-erkrankungen | |
DK0754176T3 (da) | Hidtil ukendte carbamater og urinstoffer som modifikatorer for multidrugsresistens | |
NO1994018I1 (no) | Mometasonfuroat | |
DE69725293D1 (de) | N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität | |
PT705100E (pt) | Guanidinas substituidas terapeuticas | |
BG101118A (en) | Therapeutical compounds | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
ATE171935T1 (de) | 2-amino-4-phenyl-4-oxo-buttersäure-derivate mit kynureninase und/oder kynurenin-3-hydroxylase inhibierender wirkung | |
BR9814945A (pt) | Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
EP0915087A3 (de) | Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen | |
ATE112276T1 (de) | Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. | |
ATE245421T1 (de) | Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten | |
ATE96039T1 (de) | Arzneimittel und ihre verwendung zur behandlung von parasitosen. | |
ATE180167T1 (de) | Inhibition der ausscheidung von natrium durch die na-k-atpase | |
ES2127133B1 (es) | Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |